Trace Biosciences is a biotechnology startup based in Portland, Oregon, specializing in the development of imaging agents for surgical applications. The company's mission is to revolutionize surgery by providing real-time, detailed anatomical visualization, particularly focusing on nerve-specific fluorescence contrast agents to prevent surgical nerve damage. Co-founded by Dr. Connor Barth, who serves as the CEO, Trace Biosciences has received significant funding, including a $4 million grant from OHSU and a $500,000 investment from AOBIO 2023. The company aims to enhance surgical outcomes and patient safety through innovative imaging technologies.